Susquehanna International Group, LLP Edgewise Therapeutics, Inc. Transaction History
Susquehanna International Group, LLP
- $527 Billion
- Q2 2024
A detailed history of Susquehanna International Group, LLP transactions in Edgewise Therapeutics, Inc. stock. As of the latest transaction made, Susquehanna International Group, LLP holds 16,776 shares of EWTX stock, worth $458,152. This represents 0.0% of its overall portfolio holdings.
Number of Shares
16,776
Previous 26,870
37.57%
Holding current value
$458,152
Previous $490,000
38.37%
% of portfolio
0.0%
Previous 0.0%
Shares
5 transactions
Others Institutions Holding EWTX
# of Institutions
144Shares Held
96.7MCall Options Held
45.7KPut Options Held
5.3K-
Orbimed Advisors LLC San Diego, CA15MShares$410 Million6.52% of portfolio
-
Ra Capital Management, L.P. Boston, MA8.91MShares$243 Million2.42% of portfolio
-
Novo Holdings Hellerup, G76.34MShares$173 Million8.16% of portfolio
-
Black Rock Inc. New York, NY6.02MShares$164 Million0.0% of portfolio
-
Baker Bros. Advisors LP New York, NY5.84MShares$159 Million1.4% of portfolio
About Edgewise Therapeutics, Inc.
- Ticker EWTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 63,171,700
- Market Cap $1.73B
- Description
- Edgewise Therapeutics, Inc., a biopharmaceutical company, develops small molecule therapies for musculoskeletal diseases. The Company's lead product candidate, EDG-5506, is an orally administered small molecule designed to address the root cause of dystrophinopathies including Duchenne muscular dystrophy and Becker muscular dystrophy which has c...